Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Molecular and biological characterization of a new isolate of guinea pig cytomegalovirus.

Schleiss MR, McAllister S, Armién AG, Hernandez-Alvarado N, Fernández-Alarcón C, Zabeli JC, Ramaraj T, Crow JA, McVoy MA.

Viruses. 2014 Jan 27;6(2):448-75. doi: 10.3390/v6020448.

2.

Identification of a 1.6 kb genome locus of guinea pig cytomegalovirus required for efficient viral growth in animals but not in cell culture.

Nozawa N, Yamamoto Y, Fukui Y, Katano H, Tsutsui Y, Sato Y, Yamada S, Inami Y, Nakamura K, Yokoi M, Kurane I, Inoue N.

Virology. 2008 Sep 15;379(1):45-54. doi: 10.1016/j.virol.2008.06.018. Epub 2008 Jul 24.

3.
4.

Re-evaluation of the genome sequence of guinea pig cytomegalovirus.

Kanai K, Yamada S, Yamamoto Y, Fukui Y, Kurane I, Inoue N.

J Gen Virol. 2011 May;92(Pt 5):1005-20. doi: 10.1099/vir.0.027789-0. Epub 2011 Jan 26.

PMID:
21270288
5.

Quantitative-competitive PCR monitoring of viral load following experimental guinea pig cytomegalovirus infection.

Schleiss MR, Bourne N, Bravo FJ, Jensen NJ, Bernstein DI.

J Virol Methods. 2003 Mar;108(1):103-10.

PMID:
12565160
6.
7.

A Novel Non-Replication-Competent Cytomegalovirus Capsid Mutant Vaccine Strategy Is Effective in Reducing Congenital Infection.

Choi KY, Root M, McGregor A.

J Virol. 2016 Aug 12;90(17):7902-19. doi: 10.1128/JVI.00283-16. Print 2016 Sep 1.

9.

Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genome.

Schleiss MR, McGregor A, Choi KY, Date SV, Cui X, McVoy MA.

Virol J. 2008 Nov 12;5:139. doi: 10.1186/1743-422X-5-139.

10.

Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine.

Schleiss MR, Stroup G, Pogorzelski K, McGregor A.

Vaccine. 2006 Sep 11;24(37-39):6175-86. Epub 2006 Jul 18.

PMID:
16879902
11.

Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.

Swanson EC, Gillis P, Hernandez-Alvarado N, Fernández-Alarcón C, Schmit M, Zabeli JC, Wussow F, Diamond DJ, Schleiss MR.

Vaccine. 2015 Jul 31;33(32):4013-8. doi: 10.1016/j.vaccine.2015.06.019. Epub 2015 Jun 13.

12.
13.

Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model.

Schleiss MR, Choi KY, Anderson J, Mash JG, Wettendorff M, Mossman S, Van Damme M.

Vaccine. 2014 May 13;32(23):2756-62. doi: 10.1016/j.vaccine.2013.07.010. Epub 2013 Jul 16.

15.

Repair of a Mutation Disrupting the Guinea Pig Cytomegalovirus Pentameric Complex Acquired during Fibroblast Passage Restores Pathogenesis in Immune-Suppressed Guinea Pigs and in the Context of Congenital Infection.

McVoy MA, Wang JB, Dittmer DP, Bierle CJ, Swanson EC, Fernández-Alarcón C, Hernandez-Alvarado N, Zabeli JC, Schleiss MR.

J Virol. 2016 Aug 12;90(17):7715-27. doi: 10.1128/JVI.00320-16. Print 2016 Sep 1.

16.

Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection.

Cardin RD, Bravo FJ, Pullum DA, Orlinger K, Watson EM, Aspoeck A, Fuhrmann G, Guirakhoo F, Monath T, Bernstein DI.

Vaccine. 2016 Apr 12;34(17):1993-9. doi: 10.1016/j.vaccine.2016.03.005. Epub 2016 Mar 10.

PMID:
26973071
17.

Characterization of a cluster of late genes of guinea pig cytomegalovirus.

Liu Y, Biegalke BJ.

Virus Genes. 2001 Dec;23(3):247-56.

PMID:
11778692
18.

Pathogenesis of cytomegalovirus-associated labyrinthitis in a guinea pig model.

Katano H, Sato Y, Tsutsui Y, Sata T, Maeda A, Nozawa N, Inoue N, Nomura Y, Kurata T.

Microbes Infect. 2007 Feb;9(2):183-91. Epub 2006 Dec 8.

PMID:
17208485
19.
20.

An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model.

Leviton MP, Lacayo JC, Choi KY, Hernandez-Alvarado N, Wey A, Schleiss MR.

Clin Dev Immunol. 2013;2013:906948. doi: 10.1155/2013/906948. Epub 2013 Aug 20.

Supplemental Content

Support Center